Annual Report

Overview

The report presents Sun Pharma's FY21 consolidated performance during the COVID-19 pandemic, including revenue from operations of INR 334,981.4 million and total income of INR 343,336.6 million. It reports a consolidated workforce of 37,000+ employees, with approximately 92% receiving safety and skill-upgradation training. The company invested INR 269.5 million in CSR projects and generated around 36.5 million kWh of clean energy, while reporting 2,863,563 KL of water usage and extensive waste recycling and reuse.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2021
Period: 1 April 2020 – 31 March 2021
Language: English
Pages
File size
Restatement: Disclosed

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services